
Sign up to save your podcasts
Or
This week on BioTech Nation, Dr. Peter Vanderklish, Chief Scientific Officer at Spinogenix discusses their clinical trials focused on regenerating synapses to repair brain connections and offer hope for conditions like Alzheimer's, ALS, schizophrenia and depression. Phase 2 trials are underway. Check their website for patient recruitment information.
4.1
2929 ratings
This week on BioTech Nation, Dr. Peter Vanderklish, Chief Scientific Officer at Spinogenix discusses their clinical trials focused on regenerating synapses to repair brain connections and offer hope for conditions like Alzheimer's, ALS, schizophrenia and depression. Phase 2 trials are underway. Check their website for patient recruitment information.
6,183 Listeners
4,247 Listeners
32,073 Listeners
3,395 Listeners
21,907 Listeners
2,161 Listeners
26,331 Listeners
3,371 Listeners
6,639 Listeners
9,265 Listeners
317 Listeners
30 Listeners
15,363 Listeners
3,311 Listeners
1,166 Listeners